Showing 2031-2040 of 4671 results for "".
Risk Factor: Characterizing Melanoma Risk Clinically
https://practicaldermatology.com/topics/practice-management/risk-factor-characterizing-melanoma-risk-clinically/20844/Can clinical features help determine an individual's melanoma risk?Untapped Markets: Laser Hair Removal and Laser Tattoo Removal
https://practicaldermatology.com/topics/practice-management/untapped-markets-laser-hair-removal-and-laser-tattoo-removal/21114/Despite some competition, laser hair removal and tattoo removal still offer opportunities.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21460/Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.New Findings Raise Questions About EHRs Going Forward
https://practicaldermatology.com/topics/practice-management/new-findings-raise-questions-about-ehrs-going-forward/22934/A recently published study dampens expectations for the future of EHRs, which may also signal diminished public support.New Products and Pharmacologic Developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21558/New products and pharmacologic developments
https://practicaldermatology.com/columns/new-products/new-products-and-pharmacologic-developments/21688/Evaluating Hyaluronic Acids in Patients with Skin of Color
https://practicaldermatology.com/topics/general-topics/1109_05-php/22057/One expert places new findings in perspective and explains why new data on fillers in skin of color are essential.The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.